Eudaimonia Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $371K | Hold |
1,722
| – | – | 0.09% | 176 |
|
|
2023
Q4 | $446K | Sell |
1,722
-66
| -4% | -$17.1K | 0.12% | 151 |
|
|
2023
Q3 | $460K | Sell |
1,788
-3,326
| -65% | -$855K | 0.11% | 183 |
|
|
2023
Q2 | $1.46M | Buy |
5,114
+3,072
| +150% | +$875K | 0.33% | 73 |
|
|
2023
Q1 | $568K | Hold |
2,042
| – | – | 0.14% | 156 |
|
|
2022
Q4 | $565K | Sell |
2,042
-20
| -1% | -$5.54K | 0.14% | 164 |
|
|
2022
Q3 | $551K | Sell |
2,062
-12
| -0.6% | -$3.21K | 0.14% | 157 |
|
|
2022
Q2 | $423K | Hold |
2,074
| – | – | 0.08% | 245 |
|
|
2022
Q1 | $437K | Buy |
+2,074
| New | +$437K | 0.07% | 254 |
|
|
2021
Q3 | $518K | Buy |
1,829
+430
| +31% | +$122K | 0.09% | 230 |
|
|
2021
Q2 | $484K | Buy |
1,399
+5
| +0.4% | +$1.73K | 0.09% | 232 |
|
|
2021
Q1 | $390K | Hold |
1,394
| – | – | 0.08% | 234 |
|
|
2020
Q4 | $341K | Buy |
1,394
+13
| +0.9% | +$3.18K | 0.08% | 236 |
|
|
2020
Q3 | $392K | Buy |
1,381
+94
| +7% | +$26.7K | 0.1% | 200 |
|
|
2020
Q2 | $344K | Hold |
1,287
| – | – | 0.13% | 173 |
|
|
2020
Q1 | $407K | Buy |
1,287
+36
| +3% | +$11.4K | 0.18% | 136 |
|
|
2019
Q4 | $371K | Buy |
+1,251
| New | +$371K | 0.15% | 155 |
|